Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsGaspar J. Kitange, Jann N. Sarkaria, Brett L. Carlson et al.|Neuro-Oncology|2008Cited by 387
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panelJann N. Sarkaria, C. David James, Patrick T. Grogan et al.|Molecular Cancer Therapeutics|2007Cited by 203
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft modelGaspar J. Kitange, Jann N. Sarkaria, Brett L. Carlson et al.|Journal of Neuro-Oncology|2008Cited by 97
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft linesMichelle J. Clarke, Jann N. Sarkaria, Evan A. Mulligan et al.|Molecular Cancer Therapeutics|2009Cited by 94
WITHAFERIN A: A NOVEL THERAPEUTIC APPROACH FOR MALIGANT BRAIN TUMORSPatrick T. Grogan|KU ScholarWorks (The University of Kansas)|2014Cited by 0